$1.71-0.01 (-0.58%)
Ainos, Inc., a dual-platform AI and biotech company, focusing SmellTech, AI diagnostics, and immune therapeutics.
Ainos, Inc. in the Technology sector is trading at $1.76. The stock is currently near its 52-week low of $1.26, remaining 28.5% below its 200-day moving average. Technical signals show neutral RSI of 55 and bearish MACD signal, explaining why AIMD maintains its current current market pressure. The Whystock Score of 50/100 suggests a balanced risk-reward profile.
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Ainos, Inc., a dual-platform AI and biotech company, focusing SmellTech, AI diagnostics, and immune therapeutics. Its AI Nose platform uses a smell language model to digitize scent into Smell IDs and turning invisible chemical signals into machine-re...
Among the possible implications are restoring a sense of smell and sniffing out potential health concerns.
Ainos (AIMD) announced the start of AI Nose deployments tied to its first $2.1 million order from a semiconductor back-end customer, marking the Company’s transition from preparation into operation. During the second half of 2025, Ainos carried out deployment readiness preparations. This groundwork positioned the AI Nose platform for live environments. In January 2026, Ainos commenced on-site deployments associated with its initial $2.1 million order with a leading semiconductor packaging and te
Gibo Holdings Ltd. 139,986,518 0.0516
The firm agreed to a $60,000 fine and committed to implement corrective measures before submitting any future PCAOB application.